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Summary We investigated distant recurrence and S-phase fraction (SPF), estimated by flow cytometry with
and without selection of the epithelial cell population, in 201 stage II breast carcinomas. The tumour tissue
was disintegrated mechanically by scissors and one part of the cell suspension was treated with a detergent-
trypsin method for single-parameter analysis, and the other part, for immunological selection of epithelial
cells, was incubated with a monoclonal antibody (CAM 5.2) recognising cytokeratins 8 and 18 and a
secondary fluorescein isothiocyanate-labelled antibody. DNA was stained with propidium iodide. In order to
compare the methods, statistical analysis was performed on the 152 tumours with S-phase fraction estimated
by both methods. Sixty-five tumours were diploid, 81 were aneuploid and six tumours had different ploidy
determined by the two methods. Using univariate regression analysis, SPF of the epithelial cell population
predicted recurrence more effectively than SPF from single-parameter analysis. In multivariate regression
analysis, SPF of the cytokeratin-containing population added significant prognostic information to the SPF of
the non-selected cells. We conclude that the use of flow cytometric selection ofepithelial breast carcinoma cells
enhances the predictability value of SPF.
DNA ploidy and SPF have, in several studies, shown good
predictibility value in breast carcinomas (Klintenberg et al.,
1986; Kallioniemi et al., 1987; Clark et al., 1989; Stal et al.,
1989; Lewis, 1990). Aneuploidy and high SPF are generally
associated with early distant recurrence and decreased sur-
vival time, while diploidy and low SPF correlate with good
prognosis.
Estimation of SPF in carcinomas using single-parameter
flow cytometry is complicated by the content of inflam-
matory, stromal and normal epithelial cells in the tumour.
The risk of underestimating SPF depends on the proportion
of diluting host cells (Wingren et al., 1992) and is highly
variable from tissue to tissue and within the same type of
tissue. It is, thus, impossible to introduce correction factors
because of this sample heterogeneity. The contamination of
DNA diploid cancer cells by non-neoplastic cells results in an
overlap in the diploid region of the histogram and increases
the risk of falsely low SPF values. The dilution of aneuploid
tumours with host cells decreases the ability to detect minor
populations and may introduce artifacts into the calculation
of SPF. Cancer tissue with a low proportion of DNA tetra-
ploid cells compared with diploid cells may be misinterpreted
as a DNA diploid tumour. Furthermore, overlap of the
tetraploid stemline by diploid G2/M cells makes the assess-
ment of SPF unreliable in some cases.
Although these potential pitfalls are numerous, they may
be solved using immunocytochemical technology. However,
tumour-specific markers are not available for flow cytometric
selection of cancer cells; epithelial cells normally express
cytokeratins in a tissue-specific fashion, which may be used
for identification (Moll et al., 1982). The vast majority of
normal and malignant mammary epithelial cells contain
cytokeratins 7, 8, 18 and 19. The characteristics of
cytokeratin in normal epithelia of the breast are mostly well
preserved during malignant progression and, to some extent,
even more pronounced in carcinomas (Osborn et al., 1983;
Ferrero et al., 1990; Wetzels et al., 1991). A fluorescein
isothiocyanate (FITC)-conjugated secondary antibody,
together with a primary monoclonal antibody specific for
cytokeratin, used with a suspension of cells with preserved
antigenicity, allows flow cytometric sorting of the epithelial
cell population (Zarbo et al., 1989; Visscher et al., 1990).
We have now compared the ability of SPF measured on
unselected cells and SPF estimated on immunoselected
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epithelial cells to predict recurrence of stage II breast
cancer.
Materials and methods
Two hundred and one patients with primary breast cancer in
pathological stage II (UICC), operated on between 1977 and
1990, were included in the study. The patients' median age
was 57 years and the median follow-up time was 59 months.
Seventy per cent of the tumours had oestrogen receptor levels
greater than 0.1 fmol per Lg of DNA and 35% were 20 mm
or less in diameter. Twenty per cent of the patients were
lymph node negative, while 53% and 27% had 1-3 and >3
metastatic nodes respectively. Forty-eight patients had dis-
tant recurrence during the follow-up period. The tumour
samples were kept frozen at - 70°C until analysis.
Preparationforflow cytometric analysis
In order to confirm the presence of cancer cells, touch
preparations stained with May-Grunewald-Giemsa solu-
tions were used and examined in a light microscope. The
frozen tissue was cut with scissors in a citrate buffer before
filtration through a nylon mesh (pore size 41 Im). Cell
suspensions were divided for preparation into single- and
dual-flow cytometric analysis.
The cell suspension used for flow cytometric gating on
cytokeratin-containing epithelial cells (CK) was fixed in cold
(-20'C) 70% ethanol and stored at 4°C overnight. After
centrifugation (890g), 1 ml of a PAB solution containing
phosphate-buffered saline with 0.5% serum albumin was
added. The primary mouse monoclonal antibody CAM 5.2
(Makin et al., 1984; Mygind et al., 1988), recognising
cytokeratin 8 and 18 (Becton Dickinson No. 7650), was
incubated for 30 min. The secondary fluorescein isothio-
cyanate-conjugated monoclonal antibody F(ab)2 (Dakopatts
No. F313) was added after washing and resuspension in 1 ml
of PAB. The cell suspension was washed twice before
resuspension in 600 itl of PAB solution containing RNAse
(50;Lgml-'). After aspiration with a syringe (needle diameter
0.4mm) and filtration as described above, DNA was stained
with 15tig of propidium iodide before analysis with flow
cytometry.
The cell suspension for single-parameter analysis was
prepared as described by Vindelov et al. (1983). Briefly, cells
were treated with a detergent trypsin solution before the
addition of trypsin inhibitor and spermine tetrahydroch-
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loride. Nuclei were labelled with propidium iodide prior to
flow cytometric analysis. Chicken and trout blood cells were
used as internal standards to estimate DNA index.
Flow cytometry
A FACscan flow cytometer (Becton Dickinson) equipped
with a 15 mW argon laser (488 nm) was used. Fifteen thou-
sand events were recorded in a dot plot (cytokeratin vs
DNA). A window was placed in the area of cytokeratin-
positive cells, generating a histogram for the evaluation of
SPF of the epithelial population. Histograms with fewer than
1,000 cytokeratin-positive cells were not evaluated. S-phase
fraction was calculated assuming a rectangular distribution
(Baisch et al., 1975). The number of channels between the
GO/GI and G2/M peaks was multiplied by the mean number
of cells per channel in an interval interactively selected in the
S-phase region of the histogram. Histograms including a
single GO/GI peak were defined as diploid, while tumours
with additional GO/GI stemlines were classified as non-
diploid (Hiddeman et al., 1984).
In single-parameter analysis, 15,000 events were recorded
and S-phase values were calculated as described above.
Chicken and trout blood cells were used to estimate the
DNA index.
All S-phase values were corrected for background by select-
ing an area to the right of the G2/M peak with a represen-
tative amount of debris. The mean counts per channel in this
region was subtracted from the mean number of cells in the
S-phase area. In order to reduce the number of cell clumps,
doublet discrimination was performed on the dot plot of the
area and width of the red signal.
Statistical methods
The association between SPF and recurrence rate was
analysed using the proportional hazards model described by
I .1
.
Cox (1972) and recurrence curves were calculated according
to Kaplan and Meier (1958).
Results
SPF was considered reliable in 173 (86%) tumours using the
detergent method, and 167 (83%) with the CK method.
Mean and median values of SPF are shown in Table I. The
mean coefficient of variation (CV) for the detergent-trypsin
and cytokeratin methods was 3.95 and 4.11 respectively.
In four cases an additional peak was found as a result of
the increased ability of the CK method to identify small
aneuploid stemlines. Figure 1 illustrates a non-diploid
tumour with and without selection of epithelial cells. How-
ever, the cytokeratin method yielded marginally higher DNA
values. The difference between the methods increased
significantly with increased values of DNA index. Twelve
tumours with a DNA index close to the limits of the DNA
tetraploid region using the single-parameter analysis were
thus candidates to be classified as tetraploid or hypertetra-
ploid with the cytokeratin method. With the hypodiploid
tumours, the CK method failed to identify the hypodiploid
stemlines in 4 of 10 cases.
Table I Distribution of mean and median SPF determined by the
cytokeratin method (CK) and detergent-trypsin method (DT) in the
152 patients with SPF by both methods
All tumours Diploid tumours Non-diploid
tumours
CK DT CK DT CK DT
Mean 6.0 6.1 4.6 4.1 7.1 7.8
Median 5.2 5.0 4.0 3.7 6.2 7.0
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Figure 1 Dot plots and histograms of a non-diploid tumour before a and after b selection of cytokeratin-containing cells.
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Table II Recurrence rate ratio (RR) determined by logistic regression using univariate and
multivariate analysis in 152 patients
Detergent-trypsin method Cytokeratin method
Univariate Multivariate Univariate Multivariate
n RR RR n RR RR
SPF<5 72 1.0 1.0 71 1.0 1.0
10>SPF> 5 53 1.1 0.82 58 1.4 1.4
SPF 10 27 2.7 1.4 23 4.4 3.8
Test for trend P = 0.026 P = 0.69 P = 0.0007 P = 0.0077
The logistic regression analysis was based on the 152
tumours with reliable SPF obtained by both methods. Sixty-
five tumours were diploid, including 16 recurrences, and 81
were non-diploid with 22 recurrences in both methods. In six
cases a shift in ploidy between diploid and non-diploid was
found. When SPF was used as a continuous variable in
logistic regression analysis, both the detergent-trypsin
method (X2 = 7.7, P = 0.0055) and the CK method (X2 = 19.7,
P = 0.0001) significantly predicted recurrence; however, using
multivariate analysis, only the CK method contributed
significantly (X2 = 8.14, P = 0.0043). Using the median value
(5.0%) as the cut-off point, CK-gated SPF was significantly
related to recurrence (P = 0.05), while the detergent-trypsin
method was not. Analysis with two cut-off values is shown in
Table II. As illustrated in Figure 2, SPF from the gated
population was more closely associated with distant recur-
rence than SPF from the single-parameter analysis. DNA
ploidy was unrelated to prognosis in both methods.
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Figure 2 Distant recurrence probability according to Kaplan
and Meier (1958) using SPF , 10% and SPF<10% as cut-off
value for detergent-trypsin a and cytokeratin b methods.
Discussion
An improved prediction of recurrence was found for SPF
with the immunoselection method among the 152 cases with
reliable SPF in both methods. This was found for the
different cut-off values and when SPF was used as a con-
tinuous variable. Furthermore, the CK method yielded addi-
tional prognostic information to the single-parameter
analysis, but the opposite was not true. These findings are
in agreement with a previous case-control study in stage I
and stage II euploid breast carcinomas (S. Wingren, in
press).
In order to make a reliable comparison ofthe prediction of
recurrence for SPF derived from the two methods, cells were
taken from the same suspension to reduce the effects of DNA
heterogeneity within the tumour. Also, stage II patients
rather than stage I patients were chosen to obtain a
reasonable number of events for the statistical evaluation.
However, the material is too small for subgroup analysis.
As shown by Alam et al. (1992) and in the present study,
the immunoselection technique has the capacity to discover
minor aneuploid cell populations. The slight increase in
DNA values, in some cases, may be due to the different use
of internal reference cells or an increased access of aneuploid
cells to propidium iodide compared with that of diploid cells.
Using the CK method, chicken and trout blood cells yielded
unstable DNA values and were not used to estimate DNA
index.
Median and mean values of SPF in the two methods were
similar, but a small difference was found within the diploid
and aneuploid subgroups. The increased SPF values for CK-
selected diploid tumours may reflect the exclusion of
inflammatory and stromal cells, which tend to lower the SPF
values. However, the decreased SPF values for CK-selected
aneuoploid tumours are in contrast to results obtained by
Visscher et al. (1990).
The problem of determining the prognostic value of a
continuous variable has recently been discussed (Altman,
1991; Clark et al., 1993). In order to avoid the selection of a
single cut-off point, which could favour one method, SPF
values were divided into either two or three intervals. In
addition, SPF was treated as a continuous variable in the
logistic regression analysis. Irrespective of how SPF was
categorised, its association with recurrence was strongest
after CK selection of epithelial cells.
Selection of epithelial cells includes some pitfalls. Residual
non-neoplastic epithelium may dilute the tumour population
and some cytokeratin antigenicity may be lost during
preparation. As shown by others (Gown et al., 1988;
Traweek et al., 1993) cytokeratin may be expressed by
stroma, haematopoietic and smooth muscle cells. Further-
more, some breast cancers may have diminished expression
of keratins. However, the monoclonal antibody CAM 5.2
seems to be a useful tool for selecting tumour cells, since the
majority of breast tumours express the simple epithelial
keratins 8 and 18 (Nagle et al., 1986; Ferrero et al., 1990;
Wetzels et al., 1991).
SPF derived from flow cytometric selection of epithelial
cells shows promise as a tool to identify patients with
different risks of recurrence. However, investigation of a
larger breast cancer population is needed to determine its use
in subgroups defined by DNA index or nodal status.IMMUNOSELECTED S-PHASE FRACTION BREAST CANCER 549
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